Verily | Case Study
Verily is an Alphabet company combining a data-driven, people-first approach to bring the promise of precision health to everyone, every day.“Wearable devices offer an incredible opportunity to increase diversity in clinical studies, but they need to be accessible to a broader set of users to make this vision true.” Kristin SizeHead of Study Devices, Verily
Digital health technologies, such as wearable devices, can allow for remote data collection, allowing studies to be run in a decentralized manner and capturing data in free-living situations. However, to do this, a wearable device must be designed to perform across demographically and medically diverse populations in real-world settings.
The DATAcc Framework for Inclusive Development provides targeted questions and checkpoints at each point in the development process that help ensure that inclusion stays a focus. The team used it to think about common problems associated with inclusion in wearable devices such as: skin tone, connectivity, body size, and age-related changes.
- PPG technology has innate challenges due to green light absorption varying across different skin tones. Using the Framework for Inclusive Development we focused on endpoints that would allow us to evaluate performance. In addition, we prioritized including participants with darker skin, varying hair density, and wrist size in our early technical feasibility studies to optimize the sensor design.
Access & Accessibility:
- We also completed usability testing for items like setup, wearing and care for the device, and completing ePROs.
The Impact✓ Greater patient centricity
✓ Clear communication
✓ Team education and cohesion
The Digital Medicine Society (DiMe) is a global non-profit and the professional home for all members of the digital medicine community. Together, we drive scientific progress and broad acceptance of digital medicine to enhance public health.
90 Canal Street, 4th Floor
Boston, Massachusetts 02114
Support UsDonate Here